
Join to view full profile
3 Firestone CtSkillman, NJ 08558
Phone+1 609-466-8380
Fax+1 609-818-7668
Dr. Taylor is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Mass General Brigham/Massachusetts General HospitalResidency, Internal Medicine, 1978 - 1979
Mass General Brigham/Massachusetts General HospitalInternship, Internal Medicine, 1976 - 1977
Harvard Medical SchoolClass of 1976
Certifications & Licensure
MD State Medical License 2015 - 2017
MA State Medical License 1978 - 2013
Awards, Honors, & Recognition
- Elected Member The American Society for Clinical Investigation, 1985
Clinical Trials
Publications & Presentations
PubMed
- Alpha-klotho, insulin resistance, and adiposity among older adults.Anam Ahmad, Michelle Shardell, Rita Rastogi Kalyani, Richard D Semba, Braxton D Mitchell
Journal of the Endocrine Society. 2026-07-01 - Genetics of Response to Canagliflozin (GRC) Study: Rationale, Design, and Pharmacodynamic Responses.May E Montasser, Salma A Bargal, Elizabeth A Streeten, Hilary B Whitlatch, Zhinous Shahidzadeh Yazdi
Clinical and Translational Science. 2026-06-01 - Precision Medicine: A Circulating Biomarker to Identity People With Pathogenic Variants in the INSR Gene.Simeon I Taylor, Sayna Bagheri, Elif A Oral, Toni I Pollin
The Journal of Clinical Endocrinology and Metabolism. 2025-12-18
Press Mentions
Combination Treatment Reduces Weight While Keeping MuscleJune 24th, 2025
Orforglipron Lowers A1c, Weight in Early Type 2 DiabetesJune 21st, 2025
Vitamin D Deficiency: Can We Improve Diagnosis?June 15th, 2023
Grant Support
- Tirzepatide for treatment of familial partial lipodystrophyUNIVERSITY OF MICHIGAN AT ANN ARBOR2025–2030
- Ketone Monitoring Approaches for DKA Risk Mitigation in People with T1D on Adjunctive SGLT2 Inhibitors (KARMA)ADVENTHEALTH ORLANDO2025–2028
- Pharmacogenetics of the Response to a GLP1R AgonistUNIVERSITY OF MARYLAND BALTIMORE2021–2026
- Diabetes, Obesity, and Metabolic ComplicationsUNIVERSITY OF MARYLAND BALTIMORE2015–2026
- Sorting Nexins And Intracellular Protein TraffickingNational Institute Of Diabetes And Digestive And Kidney Diseases1999–2000
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:









